Differentiation and the Cell Cycle

Vitamin D

Volumn 2, Issue , 2005, Pages 1635-1661

  Studzinski, George P ^a   Danilenko, Michael ^b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 36849083733     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012252687-9/50096-6     Document Type: Chapter

References (336)

1. Reed SI Control of the G1/S transition. Cancer Surv 1997, 29:7-23.
2. Coffman FD, Studzinski GP Differentiation-related mechanisms which suppress DNA replication. Exp Cell Res 1999, 248:58-73.
3. Sherr CJ D1 in G2. Cell Cycle 2002, 1:36-38.
4. Vermeulen K, Van Bockstaele DR, Berneman ZN The cell cycle: a review of regulation, deregulation, and therapeutic targets in cancer. Cell Prolif 2003, 36:131-149.
5. Cheng M, Sexl V, Sherr CJ, Roussel MF Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1). Proc Natl Acad Sci USA 1998, 95:1091-1096.
6. Stein GS, Lian JB, Owen TA Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FASEB J 1990, 4:3111-3123.
7. Lian JB, Stein GS, Bortell R, Owen TA Phenotype suppression: a postulated molecular mechanism for mediating the relationship of proliferation and differentiation by Fos/Jun interactions at AP-1 sites in steroid responsive promoter elements of tissue-specific genes. J Cell Biochem 1991, 45:9-14.
8. Studzinski GP, Harrison LE Differentiation-related changes in the cell cycle traverse. Int Rev Cytol 1999, 189:1-58.
9. 3 precedes the G1/G0 phase cell cycle block. Cell Prolif 1994, 27:643-654.
10. Studzinski GP, Rathod B, Wang QM, Rao J, Zhang F Uncoupling of cell cycle arrest from the expression of monocytic differentiation markers in HL60 cell variants. Exp Cell Res 1997, 232:376-387.
11. Brown G, Choudhry MA, Durham J, Drayson MT, Michell RH Monocytically differentiating HL60 cells proliferate rapidly before they mature. Exp Cell Res 1999, 253:511-518.
12. 3 or all-trans-retinoic acid. Exp Cell Res 2001, 266:126-134.
13. 3-induced differentiation of HL60 cells. J Cell Biochem 2001, 80:471-482.
14. 3 involves cell cycle arrest in G1 that is preceded by a transient proliferative burst and an increase in cyclin expression. Blood 1999, 93:2721-2729.
15. 3. Proc Natl Acad Sci USA 1981, 78:4990-4994.
16. Studzinski GP, Bhandal AK, Brelvi ZS A system for monocytic differentiation of leukemic cells HL 60 by a short exposure to 1,25-dihydroxycholecalciferol. Proc Soc Exp Biol Med 1985, 179:288-295.
17. 3 in the myeloid cell differentiation. Proc Soc Exp Biol Med 1989, 191:214-220.
18. 3: differential effects on leukemic cell growth, differentiation, and intestinal calcium absorption. Cancer Res 1990, 50:6857-6864.
19. Studzinski GP, McLane JA, Uskokovic MR Signaling pathways for vitamin D-induced differentiation: implications for therapy of proliferative and neoplastic diseases. Crit Rev Eukaryot Gene Expr 1993, 3:279-312.
20. 3 receptor mRNA in human leukemia cells HL-60. Cell Prolif 1991, 24:159-170.
21. 3 on proliferation and differentiation of Caco-2 cells. Endocrinology 1994, 134:1710-1717.
22. 3 in cultured human keratinocytes. Arch Dermatol Res 1997, 289:367-372.
23. 3 receptor (VDR) expression in HC-11 mammary cells: regulation by growth-modulatory agents, differentiation, and Ha-ras transformation. Breast Cancer Res Treat 1999, 54:123-133.
24. 3 and retinoic acid. Exp Cell Res 1999, 249:279-290.
25. O'Kelly J, Hisatake J, Hisatake Y, Bishop J, Norman A, Koeffler HP Normal myelopoiesis but abnormal T lymphocyte responses in vitamin D receptor knockout mice. J Clin Invest 2002, 109:1091-1099.
26. 2: antitumor activity against leukemia, myeloma, and colon cancer cells. J Natl Cancer Inst 2003, 95:896-905.
27. 3 receptor ablation alters mammary gland morphogenesis. Development 2002, 129:3067-3076.
28. Barsony J, Prufer K Vitamin D receptor and retinoid X receptor interactions in motion. Vitam Horm 2002, 65:345-376.
29. 3. Endocrinology 1986, 119:1406-1408.
30. Nemere I, Norman AW The rapid, hormonally stimulated transport of calcium (transcaltachia). J Bone Miner Res 1987, 2:167-169.
31. 3 stimulates expression and translocation of protein kinase Calpha and Cdelta via a nongenomic mechanism and rapidly induces phosphorylation of a 33-kDa protein in acute promyelocytic NB4 cells. J Biol Chem 1996, 271:16090-16096.
32. 3, involves nuclear vitamin D receptor (nVDR) and non-nVDR-mediated pathways. J Cell Physiol 2002, 191:198-207.
33. 3 to increase intracellular calcium and activate protein kinase C in mouse osteoblasts. J Cell Biochem 2003, 88:794-801.
34. Haussler MR, Haussler CA, Jurutka PW, Thompson PD, Hsieh JC, Remus LS, Selznick SH, Whitfield GK The vitamin D hormone and its nuclear receptor: molecular actions and disease states. J Endocrinol 1997, 154(Suppl):S57-S73.
35. Carlberg C Molecular basis of the selective activity of vitamin D analogs. J Cell Biochem 2003, 88:274-281.
36. 3 receptor: a network of coactivator interactions. Gene 2000, 246:9-21.
37. MacDonald PN, Baudino TA, Tokumaru H, Dowd DR, Zhang C Vitamin D receptor and nuclear receptor coactivators: crucial interactions in vitamin D-mediated transcription. Steroids 2001, 66:171-176.
38. Lee JW, Lee YC, Na SY, Jung DJ, Lee SK Transcriptional coregulators of the nuclear receptor superfamily: coactivators and corepressors. Cell Mol Life Sci 2001, 58:289-297.
39. Bikle DD, Tu CL, Xie Z, Oda Y Vitamin D regulated keratinocyte differentiation: role of coactivators. J Cell Biochem 2003, 88:290-295.
40. Tagami T, Lutz WH, Kumar R, Jameson JL The interaction of the vitamin D receptor with nuclear receptor corepressors and coactivators. Biochem Biophys Res Commun 1998, 253:358-363.
41. 3 in prostate and breast cancer is suppressed by a mechanism involving histone deacetylation. Recent Results Cancer Res 2003, 164:83-98.
42. Ueki N, Hayman MJ Signal-dependent N-CoR requirement for repression by the Ski oncoprotein. J Biol Chem 2003, 278:24858-24864.
43. Mackey SL, Heymont JL, Kronenberg HM, Demay MB Vitamin D receptor binding to the negative human parathyroid hormone vitamin D response element does not require the retinoid x receptor. Mol Endocrinol 1996, 10:298-305.
44. Russell J, Ashok S, Koszewski NJ Vitamin D receptor interactions with the rat parathyroid hormone gene: synergistic effects between two negative vitamin D response elements. J Bone Miner Res 1999, 14:1828-1837.
45. 3 receptor. Blood 2001, 98:3290-3300.
46. 3 receptor. Cancer Res 2002, 62:7050-7058.
47. 3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 1996, 10:142-153.
48. 3-induced myeloid cell differentiation is regulated by a vitamin D receptor-phosphatidylinositol 3-kinase signaling complex. J Exp Med 1999, 190:1583-1594.
49. 3 regulation of chick myoblast proliferation and differentiation. Mol Cell Endocrinol 1999, 153:39-45.
50. Wang X, Studzinski GP Phosphorylation of raf-1 by kinase suppressor of ras is inhibited by "MEK-specific" inhibitors PD 098059 and U0126 in differentiating HL60 cells. Exp Cell Res 2001, 268:294-300.
51. 3 analog KH1060 and the phorbol ester TPA. Cancer Lett 2002, 186:67-74.
52. 3-induced differentiation in human osteoblasts. Immunopharmacol Immunotoxicol 2002, 24:31-41.
53. 3. J Cell Biochem 2003, 89:1087-1101.
54. 3 stimulates activator protein 1 DNA-binding activity by a phosphatidylinositol 3-kinase/Ras/MEK/extracellular signal regulated kinase 1/2 and c-Jun N-terminal kinase 1-dependent increase in c-Fos, Fra1, and c-Jun expression in human keratinocytes. J Invest Dermatol 2003, 120:561-570.
55. 2+-dependent protein kinase activity and protein phosphorylation patterns in the differentiation of human promyelocytic leukemia cell line HL-60. Cancer Res 1985, 45:5159-5164.
56. Todd RF, Bury MJ, Alvarez PA, Brott DA, Liu DY Regulation of human monocyte surface antigen expression. I. Up-modulation of Mo3e antigen expression on U-937 and HL-60 cells stimulated by pharmacologic activators of protein kinase C. Blood 1986, 68:1154-1161.
57. 3 enhances phorbol ester-stimulated differentiation and protein kinase C-dependent substrate phosphorylation activity in the U937 human monoblastoid cell. Endocrinology 1987, 121:1654-1661.
58. Martell RE, Simpson RU, Hsu T Effects of protein kinase inhibitors 1(5-isoquinolinesulfonyl)-2-methylpiperazine dihydrochloride (H-7) and N-[2-guanidinoethyl]-5-isoquinolinesulfonamide hydrochloride (HA1004) on calcitriol-induced differentiation of HL-60 cells. Biochem Pharmacol 1988, 37:635-640.
59. 3-induced regulation of protein kinase C gene expression during HL-60 cell differentiation. Cell Growth Differ 1991, 2:187-194.
60. 3 regulation of phorbol ester receptors in HL-60 leukemia cells. J Biol Chem 1987, 262:5570-5575.
61. 3 in HL-60 cells. J Biol Chem 1990, 265:2370-2374.
62. Gamard CJ, Blobe GC, Hannun YA, Obeid LM Specific role for protein kinase C beta in cell differentiation. Cell Growth Differ 1994, 5:405-409.
63. 3, phospholipase D, and protein kinase C in keratinocyte differentiation. Mol Cell Endocrinol 2001, 177:173-182.
64. Wali RK, Baum CL, Sitrin MD, Bolt MJ, Dudeja PK, Brasitus TA Effect of vitamin D status on the rapid actions of 1,25-dihydroxycholecalciferol in rat colonic membranes. Am J Physiol 1992, 262:G945-G953.
65. + exchange by stimulating membrane phosphoinositide turnover and increasing cytosolic calcium in CaCo-2 cells. Endocrinology 1992, 131:1125-1133.
66. 2+]i. Am J Physiol 1994, 267:G465-G475.
67. 3 induced activation and subsequent nuclear translocation of MAPK is upstream regulated by PKC in HL-60 cells. Biochem Biophys Res Commun 1997, 241:419-426.
68. 3 receptor. Endocrinology 1992, 130:2259-2266.
69. 3 receptors synergistically in rat osteosarcoma cells. Mol Cell Endocrinol 1994, 101:159-165.
70. 3 receptors by parathyroid hormone in osteoblastic cells: role of second messenger pathways. Endocrinology 1995, 136:705-712.
71. Marcinkowska E, Wiedlocha A, Radzikowski C Evidence that phosphatidylinositol 3-kinase and p70S6K protein are involved in differentiation of HL-60 cells induced by calcitriol. Anticancer Res 1998, 18:3507-3514.
72. Liu Q, Ning W, Dantzer R, Freund GG, Kelley KW Activation of protein kinase C-zeta and phosphatidylinositol 3′-kinase and promotion of macrophage differentiation by insulin-like growth factor-I. J Immunol 1998, 160:1393-1401.
73. 3-induced differentiation of human promyelocytic leukemia cells into monocytes by costunolide, a germacranolide sesquiterpene lactone. Biochem Pharmacol 2002, 64:1233-1242.
74. 3 in musculoskeletal cells. Steroids 2002, 67:421-427.
75. 3 activate three MAPK pathways and up-regulate pRb expression in differentiating HL 60 cells. Cell Cycle 2002, 1:410-415.
76. Strniskova M, Barancik M, Ravingerova T Mitogen-activated protein kinases and their role in regulation of cellular processes. Gen Physiol Biophys 2002, 21:231-255.
77. Johnson GL, Lapadat R Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002, 298:1911-1912.
78. Pouyssegur J, Volmat V, Lenormand P Fidelity and spatio-temporal control in MAP kinase (ERKs) signaling. Biochem Pharmacol 2002, 64:755-763.
79. Chang F, Steelman LS, Lee JT, Shelton JG, Navolanic PM, Blalock WL, Franklin RA, McCubrey JA Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention. Leukemia 2003, 17:1263-1293.
80. Kornfeld K, Hom DB, Horvitz HR The ksr-1 gene encodes a novel protein kinase involved in Ras-mediated signaling in C. elegans. Cell 1995, 83:903-913.
81. Sundaram M, Han M The C. elegans ksr-1 gene encodes a novel Raf-related kinase involved in Ras-mediated signal transduction. Cell 1995, 83:889-901.
82. Stewart S, Sundaram M, Zhang Y, Lee J, Han M, Guan KL Kinase suppressor of Ras forms a multiprotein signaling complex and modulates MEK localization. Mol Cell Biol 1999, 19:5523-5534.
83. Zhang Y, Yao B, Delikat S, Bayoumy S, Lin XH, Basu S, McGinley M, Chan-Hui PY, Lichenstein H, Kolesnick R Kinase suppressor of Ras is ceramide-activated protein kinase. Cell 1997, 89:63-72.
84. Xing HR, Kolesnick R Kinase suppressor of Ras signals through Thr269 of c-Raf-1. J Biol Chem 2001, 276:9733-9741.
85. Morrison DK KSR: a MAPK scaffold of the Ras pathway?. J Cell Sci 2001, 114:1609-1612.
86. 3. J Cell Physiol 2003, 198:333-342.
87. 3 in promyelocytic NB4 leukemia cells: a structure-function study. Endocrinology 1998, 139:457-465.
88. 3 in normal human keratinocytes. J Invest Dermatol 1996, 106:1212-1217.
89. 3 stimulates activator protein-1-dependent Caco-2 cell differentiation. J Biol Chem 1999, 274:35505-35513.
90. Marcinkowska E Evidence that activation of MEK1,2/ERK 1,2 signal transduction pathway is necessary for calcitriol-induced differentiation of HL-60 cells. Anticancer Res 2001, 21:499-504.
91. 3 in HL60 cells. Cancer Res 1996, 56:264-267.
92. Solomon C, Kremer R, White JH, Rhim JS Vitamin D resistance in RAS-transformed keratinocytes: mechanism and reversal strategies. Radiat Res 2001, 155:156-162.
93. 3-induced differentiation of human leukemia HL60 cells. Exp Cell Res 2000, 258:425-437.
94. Wang X, Studzinkski GP Inhibition of p38MAP kinase potentiates the JNK/SAPK pathway and AP-1 activity in monocytic but not in macrophage or granulocytic differentiation of HL60 cells. J Cell Biochem 2001, 82:68-77.
95. Ravid A, Rubinstein E, Gamady A, Rotem C, Liberman UA, Koren R Vitamin D inhibits the activation of stress-activated protein kinases by physiological and environmental stresses in keratinocytes. J Endocrinol 2002, 173:525-532.
96. Li X, Udagawa N, Itoh K, Suda K, Murase Y, Nishihara T, Suda T, Takahashi N p38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function. Endocrinology 2002, 143:3105-3113.
97. 3 analog EB1089 induces apoptosis via a p53-independents mechanism involving p38 MAP kinase activation and suppression of ERK activity in B-cell chronic lymphocytic leukemia cells in vitro. Blood 2003, 101:2454-2460.
98. 3 activate three MAPK pathways and up-regulate pRb expression in differentiating HL 60 cells 12th Workshop on Vitamin D 2003.
99. 3-induced growth inhibition. J Biol Chem 2002, 277:25884-25892.
100. Chen F, Studzinski GP Expression of the neuronal cyclin-dependent kinase 5 activator p35Nck5a in human monocytic cells is associated with differentiation. Blood 2001, 97:3763-3767.
101. 3-treated HL60 cells. Exp Cell Res 1999, 249:422-428.
102. Chen F, Rao J, Studzinski GP Specific association of increased cyclin-dependent kinase 5 expression with monocytic lineage of differentiation of human leukemia HL60 cells. J Leukoc Biol 2000, 67:559-566.
103. Studzinski GP, Harrison JS The neuronal cyclin-dependent kinase 5 activator p35Nck5a and Cdk5 activity in monocytic cells. Leuk Lymphoma 2003, 44:235-240.
104. Harada T, Morooka T, Ogawa S, Nishida E ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egr1. Nat Cell Biol 2001, 3:453-459.
105. 3 receptor and other nonreceptor transcription factors. Mol Endocrinol 1994, 8:1593-1604.
106. Karin M, Liu Z, Zandi E AP-1 function and regulation. Curr Opin Cell Bioll 1997, 9:240-246.
107. Shaulian E, Karin M AP-1 in cell proliferation and survival. Oncogene 2001, 20:2390-2400.
108. Sherman ML, Stone RM, Datta R, Bernstein SH, Kufe DW Transcriptional and post-transcriptional regulation of c-jun expression during monocytic differentiation of human myeloid leukemic cells. J Biol Chem 1990, 265:3320-3323.
109. Owen TA, Bortell R, Yocum SA, Smock SL, Zhang M, Abate C, Shalhoub V, Aronin N, Wright KL, van Wijnen AJ, et al. Coordinate occupancy of AP-1 sites in the vitamin D-responsive and CCAAT box elements by Fos-Jun in the osteocalcin gene: model for phenotype suppression of transcription. Proc Natl Acad Sci USA 1990, 87:9990-9994.
110. Schule R, Umesono K, Mangelsdorf DJ, Bolado J, Pike JW, Evans RM Jun-Fos and receptors for vitamins A and D recognize a common response element in the human osteocalcin gene. Cell 1990, 61:497-504.
111. Lu B, Rothnagel JA, Longley MA, Tsai SY, Roop DR Differentiation-specific expression of human keratin 1 is mediated by a composite AP-1/steroid hormone element. J Biol Chem 1994, 269:7443-7449.
112. 3-mediated induction. J Biol Chem 2000, 275:47-55.
113. 3-resistant HL60 cells is preceded by reduced growth factor dependence and constitutive up-regulation of Sp1 and AP-1 transcription factors. Cancer Res 1996, 56:5513-5521.
114. 3 reduces impaiment of human osteoblast functions during cellular aging in culture. J Cell Physiol 2001, 186:298-306.
115. Bikle DD, Ng D, Tu CL, Oda Y, Xie Z Calcium-and vitamin D-regulated keratinocyte differentiation. Mol Cell Endocrinol 2001, 177:161-171.
116. 3. J Invest Dermatol 2002, 119:1109-1113.
117. Dynan WS, Tjian R Isolation of transcription factors that discriminate between different promoters recognized by RNA polymerase II. Cell 1983, 32:669-680.
118. Gidoni D, Dynan WS, Tjian R Multiple specific contacts between a mammalian transcription factor and its cognate promoters. Nature 1984, 312:409-413.
119. Ikeda K, Nagano K, Kawakami K Anomalous interaction of Sp1 and specific binding of an E-box-binding protein with the regulatory elements of the Na,K-ATPase alpha 2 subunit gene promoter. Eur J Biochem 1993, 218:195-204.
120. Dusing MR, Wiginton DA Sp1 is essential for both enhancer-mediated and basal activation of the TATA-less human adenosine deaminase promoter. Nucleic Acids Res 1994, 22:669-677.
121. Lu J, Lee W, Jiang C, Keller EB Start site selection by Sp1 in the TATA-less humans Ha-ras promoter. J Biol Chem 1994, 269:5391-5402.
122. Rao J, Zhang F, Donnelly RJ, Spector NL, Studzinski GP Truncation of Sp1 transcription factor by myeloblastin in undifferentiated HL 60 cells. J Cell Physiol 1998, 175:121-128.
123. 3. J Immunol 1994, 153:3276-3284.
124. 3 in the p27Kip1 gene promoter that lacks vitamin D response elements. J Biol Chem 1999, 274:32309-32317.
125. Medema RH, Kops GJ, Bos JL, Burgering BM AFX-like forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27Kip1. Nature 2000, 404:782-787.
126. Stahl M, Dijkers PF, Kops GJ, Lens SM, Coffer PJ, Burgering BM, Medema RH The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2. J Immunol 2002, 168:5024-5031.
127. Pardee AB G1 events and regulation of cell proliferation. Science 1989, 246:603-608.
128. Nurse P Universal control mechanism regulating onset of M-phase. Nature 1990, 344:503-508.
129. Sherr CJ G1 phase progression: cycling on cue. Cell 1994, 79:551-555.
130. Zhou BB, Elledge SJ The DNA damage response: putting checkpoints in perspective. Nature 2000, 408:433-439.
131. Peng CY, Graves PR, Thoma RS, Wu Z, Shaw AS, Piwnica-Worms H Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science 1997, 277:1501-1505.
132. Mailand N, Podtelejnikov AV, Groth A, Mann M, Bartek J, Lukas J Regulation of G2/M events by Cdc25A through phosphorylation-dependent modulation of its stability. EMBO J 2002, 21:5911-5920.
133. Elledge SJ Cell cycle checkpoints: preventing an identity crisis. Science 1996, 274:1664-1672.
134. Dou QP, Levin AH, Zhao S, Pardee AB Cyclin E and cyclin A as candidates for the restriction point protein. Cancer Res 1993, 53:1493-1497.
135. O'Connor PM, Fan S DNA damage checkpoints: implications for cancer therapy. Prog Cell Cycle Res 1996, 2:165-173.
136. Hunter T, Pines J Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell 1994, 79:573-582.
137. Morgan DO Principles of CDK regulation. Nature 1995, 374:131-134.
138. Hoyt MA Eliminating all obstacles: regulated proteolysis in the eukaryotic cell cycle. Cell 1997, 91:149-151.
139. Matsuoka M, Kato JY, Fisher RP, Morgan DO, Sherr CJ Activation of cyclin-dependent kinase 4 (cdk4) by mouse MO15-associated kinase. Mol Cell Biol 1994, 14:7265-7275.
140. Sheaff RJ Regulation of mammalian cyclin-dependent kinase 2. Methods Enzymol 1997, 283:173-193.
141. Bartkova J, Zemanova M, Bartek J Expression of CDK7/CAK in normal and tumor cells of diverse histogenesis, cell-cycle position, and differentiation. Int J Cancer 1996, 66:732-737.
142. Jinno S, Suto K, Nagata A, Igarashi M, Kanaoka Y, Nojima H, Okayama H Cdc25A is a novel phosphatase functioning early in the cell cycle. EMBO J 1994, 13:1549-1556.
143. Gautier J, Solomon MJ, Booher RN, Bazan JF, Kirschner MW cdc25 is a specific tyrosine phosphatase that directly activates p34cdc2. Cell 1991, 67:197-211.
144. Heald R, McLoughlin M, McKeon F Human weel maintains mitotic timing by protecting the nucleus from cytoplasmically activated Cdc2 kinase. Cell 1993, 74:463-474.
145. Giles N, Forrest A, Gabrielli B 14-3-3 acts as an intramolecular bridge to regualte cdc25B localization and activity. J Biol Chem 2003, 278:28580-28587.
146. Matsuoka S, Huang M, Elledge SJ Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science 1998, 282:1893-1897.
147. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B WAF1, a potential mediator of p53 tumor suppression. Cell 1993, 75:817-825.
148. Jiang H, Lin J, Su ZZ, Collart FR, Huberman E, Fisher PB Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 1994, 9:3397-3406.
149. Waga S, Hannon GJ, Beach D, Stillman B The p21 inhibitor of cyclin-dependent kianses controls DNA replication by interaction with PCNA. Nature 1994, 369:574-578.
150. Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massague J, Roberts JM, Koff A p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev 1994, 8:9-22.
151. Sheaff RJ, Groudine M, Gordon M, Roberts JM, Clurman BE Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev 1997, 11:1464-1478.
152. Tsvetkov LM, Yeh KH, Lee SJ, Sun H, Zhang H p27Kip1 ubiquitination and degradation is regulated by the SCF/Skp2 complex through phosphorylated Thr187 in p27. Curr Biol 1999, 9:661-664.
153. Carrano AC, Eytan E, Hershko A, Pagano M SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1999, 1:193-199.
154. Hara T, Kamura T, Nakayama K, Oshikawa K, Hatakeyama S Degradation of p27Kip1 at the G0-G1 transition mediated by a Skp2-independent ubiquitination pathway. J Biol Chem 2001, 276:48937-48943.
155. Boehm M, Yoshimoto T, Crook MF, Nallamshetty S, True A, Nabel GJ, Nabel EG A growth factor-dependent nuclear kinase phosphorylates p27Kip1 and regulates cell cycle progression. EMBO J 2002, 21:3390-3401.
156. Serrano M, Hannon GJ, Beach D A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993, 366:704-707.
157. Hannon GJ, Beach D p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 1994, 371:257-261.
158. Chen PL, Scully P, Shew JY, Wang JY, Lee WH Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 1989, 58:1193-1198.
159. Bartek J, Bartkova J, Lukas J The retinoblastoma protein pathway in cell cycle control and cancer. Exp Cell Res 1997, 237:1-6.
160. Magae J, Wu CL, Illenye S, Harlow E, Heintz NH Nuclear localization of DP and E2F transcrition factors by heterodimeric partners and retinoblastoma protein family members. J Cell Sci 1996, 109:1717-1726.
161. Pierce AM, Schneider-Broussard R, Philhower JL, Johnson DG Differential activities of E2F family members: unique functions in regulating transcription. Mol Carcinog 1998, 22:190-198.
162. Campanero MR, Armstrong M, Flemington E Distinct cellular factors regulate the c-myb promoter through its E2F element. Mol Cell Biol 1999, 19:8442-8450.
163. Yamasaki L Balancing proliferation and apoptosis in vivo: the Goldilocks theory of E2F/DP action. Biochim Biophys Acta 1999, 1423:M9-M15.
164. Tamrakar S, Rubin E, Ludlow JW Role of pRB dephosphorylation in cell cycle regulation. Front Biosci 2000, 5:D121-D137.
165. Brehm A, Miska EA, McCance DJ, Reid JL, Bannister AJ, Kouzarides T Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 1998, 391:597-601.
166. Magnaghi-Jaulin L, Groisman R, Naguibneva I, Robin P, Lorain S, Le Villain JP, Troalen F, Trouche D, Harel-Bellan A Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 1998, 391:601-605.
167. Hoffmann I, Draetta G, Karsenti E Activation of the phosphatase activity of human cdc25A by a cdk2-cyclin E dependent phosphorylation at the G1/S transition. EMBO J 1994, 13:4302-4310.
168. Hassepass I, Voit R, Hoffmann I Phosphorylation at serine 75 is required for UV-mediated degradation of human Cdc25A phosphatase at the S-phase checkpoint. J Biol Chem 2003, 278:29824-29829.
169. Galaktionov K, Chen X, Beach D Cdc25 cell-cycle phosphatase as a target of c-myc. Nature 1996, 382:511-517.
170. Nishitani H, Lygerou Z Control of DNA replication licensing in a cell cycle. Genes Cells 2002, 7:523-534.
171. Diffley JF, Cocker JH, Dowell SJ, Rowley A Two steps in the assembly of complexes at yeast replication origins in vivo. Cell 1994, 78:303-316.
172. Dutta A, Bell SP Initiation of DNA replication in eukaryotic cells. Annu Rev Cell Dev Biol 1997, 13:293-332.
173. Kelly TJ, Martin GS, Forsburg SL, Stephen RJ, Russo A, Nurse P The fission yeast cdc18+ gene product couples S phase to START and mitosis. Cell 1993, 74:371-382.
174. Nishitani H, Lygerou Z, Nishimoto T, Nurse P The Cdt1 protein is required to license DNA for replication in fission yeast. Nature 2000, 404:625-628.
175. Lee JK, Hurwitz J Processive DNA helicase activity of the minichromosome maintenance proteins 4, 6, and 7 complex requires forked DNA structures. Proc Natl Acad Sci USA 2001, 98:54-59.
176. McGarry TJ, Kirschner MW Geminin, an inhibitor of DNA replication, is degraded during mitosis. Cell 1998, 93:1043-1053.
177. Masai H, Sato N, Takeda T, Arai K CDC7 kinase complex as a molecular switch for DNA replication. Front Biosci 1999, 4:D834-D840.
178. Mimura S, Masuda T, Matsui T, Takisawa H Central role for cdc45 in establishing an initiation complex of DNA replication in Xenopus egg extracts. Genes Cells 2000, 5:439-452.
179. Walter J, Newport J Initiation of eukaryotic DNA replication: origin unwinding and sequential chromatin association of Cdc45, RPA, and DNA polymerase alpha. Mol Cell 2000, 5:617-627.
180. Zou L, Stillman B Assembly of a complex containing Cdc45p, replication protein A, and Mcm2p at replication origins controlled by S-phase cyclin-dependent kinases and Cdc7p-Dbf4p kinase. Mol Cell Biol 2000, 20:3086-3096.
181. Takisawa H, Mimura S, Kubota Y Eukaryotic DNA replication: from prereplication complex to initiation complex. Curr Opin Cell Biol 2000, 12:690-696.
182. Furstenthal L, Swanson C, Kaiser BK, Eldridge AG, Jackson PK Triggering ubiquitination of a CDK inhibitor at origins of DNA replication. Nat Cell Biol 2001, 3:715-722.
183. Masui Y, Markert CL Cytoplasmic control of nuclear behavior during meiotic maturation of frog oocytes. J Exp Zool 1971, 177:129-145.
184. Dulic V, Stein GH, Far DF, Reed SI Nuclear accumulation of p21Cip1 at the onset of mitosis: a role at the G2/M-phase transition. Mol Cell Biol 1998, 18:546-557.
185. Niculescu AB, Chen X, Smeets M, Hengst L, Prives C, Reed SI Effects of p21 Cip1/Waf1 at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol Cell Biol 1998, 18:629-643.
186. Sadhu K, Reed SI, Richardson H, Russell P Human homolog of fission yeast cdc25 mitotic inducer is predominantly expressed in G2. Proc Natl Acad Sci USA 1990, 87:5139-5143.
187. Strausfeld U, Fernandez A, Capony JP, Girard F, Lautredou N, Derancourt J, Labbe JC, Lamb NJ Activation of p34cdc2 protein kinase by microinjection of human cdc25C into mammalian cells. Requirement for prior phosphorylation of cdc25C by p34cdc2 on sites phosphorylated at mitosis. J Biol Chem 1994, 269:5989-6000.
188. Hoffmann I, Clarke PR, Marcote MJ, Karsenti E, Draetta G Phosphorylation and activation of human cdc25-C by cdc2-cyclin B and its involvement in the self-amplification of MPF at mitosis. EMBO J 1993, 12:53-63.
189. Parker LL, Sylvestre PJ, Byrnes MJ, Liu F, Piwnica-Worms H Identification of a 95-kDa WEE1-like tyrosine kinase in HeLa cells. Proc Natl Acad Sci USA 1995, 92:9638-9642.
190. Nasmyth K, Peters JM, Uhlmann F Splitting the chromosome: cutting the ties that bind sister chromatids. Science 2000, 288:1379-1385.
191. Uhlmann F, Wernic D, Poupart MA, Koonin EV, Nasmyth K Cleavage of cohesin by the CD clan protease separin triggers anaphase in yeast. Cell 2000, 103:375-386.
192. Waizenegger IC, Hauf S, Meinke A, Peters JM Two distinct pathways remove mammalian cohesin from chromosome arms in prophase and from centromeres in anaphase. Cell 2000, 103:399-410.
193. Stemmann O, Zou H, Gerber SA, Gygi SP, Kirschner MW Dual inhibition of sister chromatid separation at metaphase. Cell 2001, 107:715-726.
194. Zachariae W, Nasmyth K Whose end is destruction: cell division and the anaphase-promoting complex. Genes Dev 1999, 13:2039-2058.
195. Donaldson MM, Tavares AA, Hagan IM, Nigg EA, Glover DM The mitotic roles of Polo-like kinase. J Cell Sci 2001, 114:2357-2358.
196. Tsvetkov L, Xu X, Li J, Stern DF Polo-like kinase 1 and Chk2 interact and co-localize to centrosomes and the midbody. J Biol Chem 2003, 278:8468-8475.
197. 3. Endocrinology 1983, 113:1950-1957.
198. 3 analogs in a cell density-, calcium- and serumdependent manner. Pharmacol Toxicol 1997, 80:49-56.
199. Light BW, Yu WD, McElwain MC, Russell DM, Trump DL, Johnson CS Potentiation of cisplatin antitumor activity using a vitamin D analog in a murine squamous cell carcinoma model system. Cancer Res 1997, 57:3759-3764.
200. 3 effects on cell cycle. J Dermatol Sci 1998, 17:108-114.
201. 3 reverses the G1 block but not differentiation of HL60 cells. Leukemia 1998, 12:1256-1265.
202. Reitsma PH, Rothberg PG, Astrin SM, Trial J, Bar-Shavit Z, Hall A, Teitelbaum SL, Kahn AJ Regulation of myc gene expression in HL-60 leukemia cells by a vitamin D metabolite. Nature 1983, 306:492-494.
203. Studzinski GP Oncogenes, growth, and the cell cycle: an overview. Cell Tissue Kinet 1989, 22:405-424.
204. Wang QM, Luo X, Studzinski GP Cyclin-dependent kinase 6 is the principal target of p27/Kip1 regulation of the G1-phase traverse in 1,25-dihydroxyvitamin D3-treated HL60 cells. Cancer Res 1997, 57:2851-2855.
205. Steinman RA, Hoffman B, Iro A, Guillouf C, Liebermann DA, el-Houseini ME Induction of p21WAF-1/CIP1 during differentiation. Oncogene 1994, 9:3389-3396.
206. Parker SB, Eichele G, Zhang P, Rawls A, Sands AT, Bradley A, Olson EN, Harper JW, Elledge SJ p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science 1995, 267:1024-1027.
207. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 1995, 82:675-684.
208. Missero C, Di Cunto F, Kiyokawa H, Koff A, Dotto GP The absence of p21Cip1/WAF1 alters keratinocyte growth and differentiation and promotes ras-tumor progression. Genes Dev 1996, 10:3065-3075.
209. Harvat BL, Wang A, Seth P, Jetten AM Up-regulation of p27Kip1, p21WAF1/Cip1 and p16Ink4a is associated with, but not sufficient for, induction of squamous differentiation. J Cell Sci 1998, 111:1185-1196.
210. 3) inhibits the growth of squamous cell carcinoma and down-modulates p21Waf1/Cip1 in vitro and in vivo. Cancer Res 1999, 59:2644-2649.
211. 3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation. Endocrinology 1998, 139:1197-1207.
212. 3 growth inhibition in the LNCaP prostate cancer cell line through p21WAF1. J Urol 2001, 165:1319-1324.
213. 3 are mediated by increased levels of p21 in the prostatic carcinoma cell line ALVA-31. Cancer Res 2001, 61:7122-7129.
214. 3 and its analog, EB1089, in human breast cancer cells. Oncogene 1997, 15:1555-1563.
215. 3 on the cell cycle genes, cyclin D1, p21, and p27 in MCF-7 cells. Mol Cell Endocrinol 1998, 142:57-65.
216. 3 on the G1-S phase-controlling machinery. Mol Endocrinol 2001, 15:1370-1380.
217. Cozzolino M, Lu Y, Finch J, Slatopolsky E, Dusso AS p21WAF1 and TGF-alpha mediate parathyroid growth arrest by vitamin D and high calcium. Kidney Int 2001, 60:2109-2117.
218. Kawa S, Nikaido T, Aoki Y, Zhai Y, Kumagai T, Furihata K, Fujii S, Kiyosawa K Vitamin D analogs up-regulate p21 and p27 during growth inhibition of pancreatic cancer cell lines. Br J Cancer 1997, 76:884-889.
219. 3 induces elevated expression of the cell cycle-regulating genes P21 and p27 in squamous carcinoma cell lines of the head and neck. Acta Otolaryngol 2001, 121:103-109.
220. 3 induces differentiation of a retinoic acid-resistant acute promyelocytic leukemia cell line (UF-1) associated with expression of p21WAF1/CIP1 and p27KIP1. Blood 1999, 93:2225-2233.
221. 3 analog EB1089 in head and neck squamous cell carcinoma. J Natl Cancer Inst 2001, 93:745-753.
222. 3 in primary, but not immortalized, mouse embryonic fibroblasts. J Biol Chem 2002, 277:37301-37306.
223. LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS, Fattaey A, Harlow E New functional activities for the p21 family of CDK inhibitors. Genes Dev 1997, 11:847-862.
224. Cheng M, Olivier P, Diehl JA, Fero M, Roussel MF, Roberts JM, Sherr CJ The p21Cip1 and p27Kip1 CDK "inhibitors" are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J 1999, 18:1571-1583.
225. Polyak K, Lee MH, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P, Massague J Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimito genic signals. Cell 1994, 78:59-66.
226. Reynisdottir I, Polyak K, Iavarone A, Massague J Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes Dev 1995, 9:1831-1845.
227. Vlach J, Hennecke S, Amati B Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27. EMBO J 1997, 16:5334-5344.
228. Montagnoli A, Fiore F, Eytan E, Carrano AC, Draetta GF, Hershko A, Pagano M Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation. Genes Dev 1999, 13:1181-1189.
229. Hengst L, Reed SI Translational control of p27Kip1 accumulation during the cell cycle. Science 1996, 271:1861-1864.
230. Lin R, Wang TT, Miller WH, White JH Inhibition of F-Box protein p45/SKP2 expression and stabilization of cyclin-dependent kinase inhibitor p27KIP1 in vitamin D analog-treated cancer cells. Endocrinology 2003, 144:749-753.
231. Spruck C, Strohmaier H, Watson M, Smith AP, Ryan A, Krek TW, Reed SI A CDK-independent function of mammalian Cks1: targeting of SCF/Skp2 to the CDK inhibitor p27Kip1. Mol Cell 2001, 7:639-650.
232. Juan G, Li X, Darzynkiewicz Z Phosphorylation of retinoblastoma protein assayed in individual HL-60 cells during their proliferation and differentiation. Exp Cell Res 1998, 244:83-92.
233. Clarke AR, Maandag ER, van Roon M, van der Lugt NM, van der Valk M, Hooper ML, Berns A, te Riele H Requirement for a functional Rb-1 gene in murine development. Nature 1992, 359:328-330.
234. Lee EY, Chang CY, Hu N, Wang YC, Lai CC, Herrup K, Lee WH, Bradley A Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 1992, 359:288-294.
235. Condorelli GL, Testa U, Valtieri M, Vitelli L, De Luca A, Barberi T, Montesoro E, Campisi S, Giordano A, Peschle C Modulation of retinoblastoma gene in normal adult hematopoiesis: peak expression and functional role in advanced erythroid differentiation. Proc Natl Acad Sci USA 1995, 92:4808-4812.
236. Hiebert SW, Lipp M, Nevins JR E1A-dependent transactivation of the human MYC promoter is mediated by the E2F factor. Proc Natl Acad Sci USA 1989, 86:3594-3598.
237. Roussel MF, Davis JN, Cleveland JL, Ghysdael J, Hiebert SW Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1. Oncogene 1994, 9:405-415.
238. Ishida S, Shudo K, Takada S, Koike K A direct role of transcription factor E2F in c-myc gene expression during granulocytic and macrophage-like differentiation of HL60 cells. Cell Growth Differ 1995, 6:229-237.
239. Watanabe T, Sariban E, Mitchell T, Kufe D Human c-myc and N-ras expression during induction of HL-60 cellular differentiation. Biochem Biophys Res Commun 1985, 126:999-1005.
240. Brelvi ZS, Studzinski GP Changes in the expression of oncogenes encoding nuclear phosphoproteins but not c-Ha-ras have a relationship to monocytic differentiation of HL 60 cells. J Cell Biol 1986, 102:2234-2243.
241. Dang CV, Resar LM, Emison E, Kim S, Li Q, Prescott JE, Wonsey D, Zeller K Function of the c-myc oncogenic transcription factor. Exp Cell Res 1999, 253:63-77.
242. Nesbit CE, Tersak JM, Prochownik EV MYC oncogenes and human neoplastic disease. Oncogene 1999, 18:3004-3016.
243. Brelvi ZS, Studzinski GP Coordinate expression of c-myc, c-myb, and histone H4 genes in reversibly differentiating HL 60 cells. J Cell Physiol 1987, 131:43-49.
244. Coller HA, Grandori C, Tamayo P, Colbert T, Lander ES, Eisenman RN, Golub TR Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. Proc Natl Acad Sci USA 2000, 97:3260-3265.
245. Gartel AL, Ye X, Goufman E, Shianov P, Hay N, Najmabadi F, Tyner AL Myc represses the p21WAF1/CIP1 promoter and interacts with Sp1/Sp3. Proc Natl Acad Sci USA 2001, 98:4510-4515.
246. Gartel AL, Shchors K Mechanisms of c-myc-mediated transcriptional repression of growth arrest genes. Exp Cell Res 2003, 283:17-21.
247. 3 regulation of c-myc protooncogene transcription. Possible involvement of protein kinase C. J Biol Chem 1989, 264:19710-19715.
248. 3 regulation of c-Myc during HL-60 cell differentiation and the involvement of HOXB4. J Biol Chem 1999, 274:8437-8444.
249. 3 inhibition of c-myc expression. J Endocrinol 2001, 169:153-159.
250. Shen WF, Largman C, Lowney P, Corral JC, Detmer K, Hauser CA, Simonitch TA, Hack FM, Lawrence HJ Lineage-restricted expression of homeobox-containing genes in human hematopoietic cell lines. Proc Natl Acad Sci USA 1989, 86:8536-8540.
251. Celetti A, Barba P, Cillo C, Rotoli B, Boncinelli E, Magli MC Characteristic patterns of HOX gene expression in different types of human leukemia. Int J Cancer 1993, 53:237-244.
252. Magli MC, Largman C, Lawrence HJ Effects of HOX homeobox genes in blood cell differentiation. J Cell Physiol 1997, 173:168-177.
253. Lill MC, Fuller JF, Herzig R, Crooks GM, Gasson JC The role of the homeobox gene, HOX B7, in human myelomonocytic differentiation. Blood 1995, 85:692-697.
254. 3 induction in myeloid leukemic cells. Mol Cell Biol 1998, 18:1911-1918.
255. Wilson AJ, Velcich A, Arango D, Kurland AR, Shenoy SM, Pezo RC, Levsky JM, Singer RH, Augenlicht LH Novel detection and differential utilization of a c-myc transcriptional block in colon cancer chemoprevention. Cancer Res 2002, 62:6006-6010.
256. 3 in the murine myelomonocytic leukemia cell line WEHI-3. Cancer Res 1986, 46:6316-6321.
257. 3. Cell Prolif 1994, 27:37-46.
258. 3-induced retardation of the G2/M traverse is associated with decreased levels of p34/cdc2 in HL60 cells. J Cell Biochem 1999, 75:226-234.
259. 3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture. Endocrinology 1981, 108:1083-1086.
260. Liu W, Asa SL, Fantus IG, Walfish PG, Ezzat S Vitamin D arrests thyroid carcinoma cell growth and induces p27 dephosphorylation and accumulation through PTEN/akt-dependent and-independent pathways. Am J Pathol 2002, 160:511-519.
261. Liu W, Asa SL, Ezzat S Vitamin D and its analog EB1089 induce p27 accumulation and diminish association of p27 with Skp2 independent of PTEN in pituitary corticotroph cells. Brain Pathol 2002, 12:412-419.
262. 3-resistant variant can be sensitized by TPA. J Steroid Biochem Mol Biol 2003, 84:199-209.
263. 3 protects HL60 cells against apoptosis but down-regulates the expression of the bcl-2 gene. Exp Cell Res 1993, 209:367-374.
264. 3 of a deoxycytidine kinase-deficient variant of human leukemia HL60 cells. Exp Cell Res 1992, 203:244-250.
265. 3-resistant human chronic myelogenous leukemia cell line. Blood 1994, 84:4283-4294.
266. 3 analogue and anti-activator protein 1 retinoid. Br J Cancer 1999, 79:101-107.
267. 3 analogs and paclitaxel on the growth of MCF-7 breast cancer cells in vivo. Breast Cancer Res Treat 1999, 53:113-120.
268. Danilenko M, Wang X, Studzinski GP Carnosic acid and promotion of monocytic differentiation of HL60-G cells initiated by other agents. J Natl Cancer Inst 2001, 93:1224-1233.
269. 3-induced apoptosis in association with increased mitogen-activated protein kinase kinase kinase 1 (MEKK-1) expression. Mol Cancer Ther 2002, 1:821-829.
270. Ahmed S, Johnson CS, Rueger RM, Trump DL Calcitriol (1,25-dihydroxycholecalciferol) potentiates activity of mitoxantrone/dexamethasone in an androgen independent prostate cancer model. J Urol 2002, 168:756-761.
271. 3 in leukemia cells, but does not promote elevation of basal levels of intracellular calcium. Cancer Res 2003, 63:1325-1332.
272. Griffin JD, Ritz J, Nadler LM, Schlossman SF Expression of myeloid differentiation antigens on normal and malignant myeloid cells. J Clin Invest 1981, 68:932-941.
273. 3: comparison with the maturation of normal monocytic and granulocytic bone marrow cells. J Leukoc Biol 1995, 58:547-555.
274. Yam LT, Li CY, Crosby WH Cytochemical identification of monocytes and granulocytes. Am J Clin Pathol 1971, 55:283-290.
275. Olsson I, Gullberg U, Ivhed I, Nilsson K Induction of differentiation of the human histiocytic lymphoma cell line U-937 by 1alpha,25-dihydroxycholecalciferol. Cancer Res 1983, 43:5862-5867.
276. Blair OC, Carbone R, Sartorelli AC Differentiation of HL-60 promyelocytic leukemia cells monitored by flow cytometric measurement of nitro blue tetrazolium (NBT) reduction. Cytometry 1985, 6:54-61.
277. 3-induced monocyte antimycobacterial activity is regulated by phosphatidylinositol 3-kinase and mediated by the NADPH-dependent phagocyte oxidase. J Biol Chem 2001, 276:35482-35493.
278. Gum JR, Kam WK, Byrd JC, Hicks JW, Sleisenger MH, Kim YS Effects of sodium butyrate on human colonic adenocarcinoma cells. Induction of placental-like alkaline phosphatase. J Biol Chem 1987, 262:1092-1097.
279. Giuliano AR, Franceschi RT, Wood RJ Characterization of the vitamin D receptor from the Caco-2 human colon carcinoma cell line: effect of cellular differentiation. Arch Biochem Biophys 1991, 285:261-269.
280. Gaschott T, Stein J Short-chain fatty acids and colon cancer cells: the vitamin D receptor-butyrate connection. Recent Results Cancer Res 2003, 164:247-257.
281. Saini K, Steele G, Thomas P Induction of carcinoembryonic-antigen-gene expression in human colorectal carcinoma by sodium butyrate. Biochem J 1990, 272:541-544.
282. Buras RR, Shabahang M, Davoodi F, Schumaker LM, Cullen KJ, Byers S, Nauta RJ, Evans SR The effect of extracellular calcium on colonocytes: evidence for differential responsiveness based upon degree of cell differentiation. Cell Prolif 1995, 28:245-262.
283. 3 specific regulation of growth, morphology, and fibronectin in a human osteosarcoma cell line. J Cell Physiol 1985, 123:401-409.
284. 3-analogs on osteoblast-like cells and on in vitro bone resorption. J Steroid Biochem Mol Biol 1995, 55:337-346.
285. 3 and thyroid hormones. Cell Biol Int 2003, 27:459-468.
286. Pernalete N, Mori T, Nishii Y, Statopolsky E, Brow AJ The activity of 22-oxacalcitriol in osteoblast-like (ROS 17/2.8) cells. Endocriology 1991, 129:778-784.
287. 3 on differentiation of a human osteosarcoma (MG-63). J Biol Chem 1992, 267:8943-8949.
288. 3 receptors and actions in human prostate cancer cell lines. Endocrinology 1993, 132:1952-1960.
289. Esquenet M, Swinnen JV, Heyns W, Verhoeven G Control of LNCaP proliferation and differentiation: actions and interactions of androgens, 1alpha,25-dihydroxycholecalciferol, all-trans retinoic acid 9-cis retinoic acid, and pheylacetate. Prostate 1996, 28:182-194.
290. 3 analog involves the induction of p21 waf1, p27kip1, and E-cadherin. J Mol Endocrinol 1997, 19:15-27.
291. Hedlund TE, Moffatt KA, Uskokovic MR, Miller GJ Three synthetic vitamin D analogs induce prostate-specific acid phosphatase and prostate-specific antigen while inhibiting the growth of human prostate cancer cells in a vitamin D receptor-dependent fashion. Clin Cancer Res 1997, 3:1331-1338.
292. 2. Prostate 2003, 55:159-167.
293. Otto T, Rembrink K, Goepel M, Meye-Schwickerath M, Rubben H E-cadherin: a marker for differentiation and invasiveness in prostatic carcinoma. Urol Res 1993, 21:359-362.
294. 3 analogs: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines. Cancer Res 1995, 55:2822-2830.
295. 5 in T47D human breast cancer cells and its interaction with vitamin D receptors. Eur J Cancer 2000, 36:780-786.
296. 3 and retinoic acid analogs induce differentiation in breast cancer cells with function- and cell-specific additive effects. Breast Cancer Res Treat 2001, 67:157-168.
297. 5. Int J Oncol 2000, 16:65-73.
298. Lanks KW, Dorwin JM, Papirmeister B Increased rate of acetylcholinesterase synthesis in differentiating neuroblastoma cells. J Cell Biol 1974, 63:824-830.
299. 3 analogs inhibit growth and induce differentiation in LA-N-5 human neuroblastoma cells. Clin Exp Metastasis 1996, 14:239-245.
300. 3 on LA-N-5 human neuroblastoma cells and its synergy with retinoic acid. J Pediatr Hematol Oncol 1995, 17:311-317.
301. 3 and retinoic acid. Cancer Res 1985, 45:1474-1478.
302. Mason RS, Pryke AM, Ranson M, Thomas HE, Posen S Human melanoma cells: functional modulation by calciotropic hormones. J Invest Dermatol 1988, 90:834-840.
303. 3 stimulates differentiation of squamous carcinoma cell line in the raft culture. Anticancer Res 1996, 16:337-347.
304. Rice RH, Green H Relation of protein synthesis and transglutaminase activity to formation of the cross-linked envelope during terminal differentiation of the cultured human epidermal keratinocyte. J Cell Biol 1978, 76:705-711.
305. Murphy GF, Flynn TC, Rice RH, Pinkus GS Involcin expression in normal and neoplastic human skin: a marker for keratinocyte differentiation. J Invest Dermatol 1984, 82:453-457.
306. Lee E, Jeon SH, Yi JY, Jin JY, Son YS Calcipotriol inhibits autocrine phosphorylation of EGF receptor in a calcium-dependent manner, a possible mechanism for its inhibition of cell proliferation and stimulation of cell differentiation. Biochem Biophys Res Commun 2001, 284:419-425.
307. 3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions. J Invest Dermatol 1986, 86:709-714.
308. 3 and its analogs, tacalcitol, calcipotriol, and maxacalcitol on normal human keratinocyte proliferation and differentiation. J Dermatol Sci 2003, 31:21-28.
309. Steven AC, Steinert PM Protein composition of cornified cell envelopes of epidermal keratinocytes. J Cell Sci 1994, 107:693-700.
310. 3 increases human cystatin A expression by inhibiting the Raf1/MEK1/ERK signaling pathway of keratinocytes. Arch Dermatol Res. 2003, [Epub ahead of print].
311. Bikle DD, Gee E, Pillai S Regulation of keratiocyte growth, differentiation, and vitamin D metabolism by analogs of 1,25-dihydroxyvitamin D. J Invest Dermatol 1993, 101:713-718.
312. Strohman RC, Paterson B, Fluck R, Przybyla A Cell fusion and terminal differentiation of myogenic cells in culture. J Anim Sci 1974, 38:1103-1110.
313. 3. Biochim Biophys Acta 1989, 1014:112-119.
314. Schwaller J, Koeffler HP, Niklaus G, Loetscher P, Nagel S, Fey MF, Tobler A Posttranscriptional stabilization underlies p53-independent induction of p21WAF1/CIP1/SDI1 in differentiating human leukemic cells. J Clin Invest 1995, 95:973-979.
315. Munker R, Kobayashi T, Elstner E, Norman AW, Uskokovic M, Zhang W, Andreeff M, Koeffler HP A new series of vitamin D analogs is highly active for clonal inhibition, differentiation, and induction of WAF1 in myeloid leukemia. Blood 1996, 88:2201-2209.
316. Asada M, Yamada T, Ichijo H, Delia D, Miyazono K, Fukumuro K, Mizutani S Apoptosis inhibitory activity of cytoplasmic p21 Cip1/WAF1 in monocytic differentiation. EMBO J 1999, 18:1223-1234.
317. Asada M, Yamada T, Fukumuro K, Mizutani S p21Cip1/WAF1 is important for differentiation and survival of U937 cells. Leukemia 1998, 12:1944-1950.
318. Asou H, Koike M, Elstner E, Cambell M, Le J, Uskokovic MR, Kamada N, Koeffler HP 19-nor vitamin-D analogs: a new class of potent inhibitors of proliferation and inducers of differentiation of human myeloid leukemia cell lines. Blood 1998, 92:2441-2449.
319. 3 analogs: disassociation of their prominent antileukemic effects from their lack of calcium modulation. Cancer Res 2001, 61:3361-3368.
320. 3 analog, EB1089, on G1 cell cycle regulatory proteins in HL-60 cells. Int J Oncol 2000, 16:315-320.
321. Yang ES, Maiorino CA, Roos BA, Knight SR, Burnstein KL Vitamin D-mediated growth inhibition of an androgenablated LNCaP cell line model of human prostate cancer. Mol Cell Endocrinol 2002, 186:69-79.
322. Yang ES, Burnstein KL Vitamin D inhibits G1 to S phase progression in LNCaP prostate cancer cells through p27kip1 stabilization and Cdk2 mislocalization to the cytoplasm. J Biol Chem 2003, 268:46862-46868.
323. 3 and its analogs on induction of apoptosis in breast cancer cells. J Steroid Biochem Mol Biol 1996, 58:395-401.
324. 3-resistant variant. Endocrinology 1997, 138:4690-4698.
325. 3 in breast cancer cells. Cancer Res 2000, 60:5578-5583.
326. 3: a novel class of potent inhibitors of proliferation of human breast cell lines. Cancer Res 1997, 57:4545-4550.
327. 3: a new class of potent inhibitors of proliferation of prostate, breast, and myeloid leukemic cells. Cancer Res 1999, 59:4023-4029.
328. 3 inhibit the growth of human breast cancer cells in vitro and in vivo. Cancer Res 2000, 60:2673-2679.
329. Flanagan L, Packman K, Juba B, O'Neill S, Tenniswood M, Welsh J Efficacy of vitamin D compounds to modulate estrogen receptor negative breast cancer growth and invasion. J Steroid Biochem Mol Biol 2003, 84:181-192.
330. Galbiati F, Polastri L, Thorens B, Dupraz P, Fiorina P, Cavallaro U, Christofori G, Davalli AM Molecular pathways involved in the antineoplastic effects of calcitriol on insulinoma cells. Endocrinology 2003, 144:1832-1841.
331. 3 analog (Ro 25-6760) inhibits human colon cancer in vitro via apoptosis. Int J Oncol 1999, 14:979-985.
332. 3 analog induces a G1-phase arrest in CaCo-2 cells by inhibiting cdk2 and cdk6: roles of cyclin E, p21Waf1, and p27Kip1. Endocrinology 2000, 141:3931-3939.
333. Gaschott T, Wachtershauser A, Steinhilber D, Stein J 1,25-dihydroxycholecalciferol enhances butyrate-induced p21Waf1/Cip1 expression. Biochem Biophys Res Commun 2001, 283:80-85.
334. Gaschott T, Steinmeyer A, Steinhilber D, Stein J ZK 156718, a low calcemic, antiproliferative, and prodifferentiating vitamin D analog. Biochem Biophys Res Commun 2002, 290:504-509.
335. 3 on the proliferation of human neuroblastoma: role of cell cycle regulators and the Myc-Id2 pathway. Biochem Pharmacol 2003, 65:1943-1955.
336. 3 analog, KH1060 in human neuroblastoma: induction of RAR-beta and p21Cip1. Cancer Lett 2003, 190:51-60.